Observational study on Hepatitis D patients in France
DELTA DESCRIBE: the French Collaborative Project
University Hospital, Limoges · NCT05936073
This study looks at Hepatitis D patients in France to see how many are being tested and treated, and aims to find ways to make it easier for them to get the care they need.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 734 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Limoges (other) |
| Locations | 1 site (Limoges) |
| Trial ID | NCT05936073 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a comprehensive overview of Hepatitis Delta virus (HDV) patients in metropolitan France over one year. It will assess the number of HDV tests conducted and compare these figures to the expected number based on Hepatitis B virus (HBV) screenings. The study will utilize data from French Health insurance and private and hospital laboratories to identify barriers to screening and care for HDV patients. The ultimate goal is to propose solutions to improve screening and treatment access for these patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who are HDV RNA positive and consent to data collection.
Not a fit: Patients who oppose the collection of their data will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance screening and treatment pathways for Hepatitis D patients, leading to better health outcomes.
How similar studies have performed: While there is limited epidemiological data on HDV in France, similar studies in other regions have successfully identified barriers to screening and care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * \>18 years at the second step * HDV RNA positive patients identified at the second step * Patients non opposed to the collection of their data Exclusion Criteria: * Opposition expressed by the patients for the collection of their data
Where this trial is running
Limoges
- Chu Limoges — Limoges, France (RECRUITING)
Study contacts
- Principal investigator: Véronique Loustaud-Ratti, Pr — University Hospital, Limoges
- Study coordinator: Sandra Juge
- Email: Sandra.Juge@chu-limoges.fr
- Phone: 0555056414
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hepatitis D, HBs Ag, Delta hepatitis, Screening, Reflex testing